
Phenopolis Ltd is a London-based health-tech company established in 2018, specializing in developing quality software for healthcare and scientific research. The company focuses on genetics, methylation, and image analysis, offering products like Trial Sense, an AI-powered Clinical Trial Management System, and Vision Sense, a Vendor Neutral Archive imaging platform. With a strong scientific and medical background, Phenopolis aims to drive innovation in medical research globally, currently deployed in over 100 NHS sites for oncology trials and multiple sites in the UK and Japan for ophthalmic clinical trials.

Phenopolis Ltd is a London-based health-tech company established in 2018, specializing in developing quality software for healthcare and scientific research. The company focuses on genetics, methylation, and image analysis, offering products like Trial Sense, an AI-powered Clinical Trial Management System, and Vision Sense, a Vendor Neutral Archive imaging platform. With a strong scientific and medical background, Phenopolis aims to drive innovation in medical research globally, currently deployed in over 100 NHS sites for oncology trials and multiple sites in the UK and Japan for ophthalmic clinical trials.